Two Leading Biotech Publications Report On Advaxis, Inc.'s Potential Treatment For Cervical Cancer

PRINCETON, N.J.--(BUSINESS WIRE)--Dec. 12, 2005--Two leading biotech publications reported that Advaxis, Inc. (ADXS.OB) successfully demonstrated in testing of mice at the University of Pennslyvania that a live listeria vaccine can eradicate existing, rapidly-growing breast tissue tumors.

MORE ON THIS TOPIC